KEPPRA TABS (Levetiracetam) by GSK

Description

Keppra Tablets (Levetiracetam) by GSK is a second-generation antiepileptic medication widely used as monotherapy or adjunctive therapy in the management of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and children. It works through a unique mechanism by binding to synaptic vesicle protein SV2A in the brain, modulating neurotransmitter release and reducing abnormal excessive neuronal firing that leads to seizure activity, distinguishing it from conventional antiepileptic drugs. A key advantage of Levetiracetam is its favorable pharmacokinetic profile, with rapid and complete oral absorption, minimal protein binding, no significant hepatic metabolism, and negligible drug interactions, making it a safe and convenient option for patients on multiple medications. Being a GSK product, Keppra is a trusted and globally recognized antiepileptic brand, offering consistent quality and efficacy in seizure management with good tolerability and a well-established long-term safety profile in both adult and pediatric epilepsy care.